BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1107252)

  • 21. Effects of cyclosporin A on the generation of primed lymphocytes in vitro.
    Leapman SB; Filo RS; Smith EJ; Smith PG
    Transplant Proc; 1980 Jun; 12(2):246-51. PubMed ID: 7394879
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemical-induced immunomodulation.
    Koller LD
    J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
    [No Abstract]   [Full Text] [Related]  

  • 23. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man.
    Wasik M; Stepień-Sopniewska B; Kozakiewicz A; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):117-20. PubMed ID: 1804040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective suppression of humoral and cellular immunity with cytosine arabinoside.
    Griswold DE; Heppner GH; Calabresi P
    Cancer Res; 1972 Feb; 32(2):298-301. PubMed ID: 4550745
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive therapy using cytostatics].
    Schumacher K; Ricken D
    Internist (Berl); 1971; 12():Suppl 1:142-8. PubMed ID: 4944100
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppressive effect of corticosteroids on rabbit's humoral and cellular response.
    Oehling A; Crisci CD; Sanz ML; Subirá ML
    Allergol Immunopathol (Madr); 1976; 4(4):255-68. PubMed ID: 1086585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus.
    Boitard C; Bach JF
    Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental models in the search for new treatments of autoimmune renal diseases.
    Bach MA; Droz D
    Adv Nephrol Necker Hosp; 1980; 9():187-208. PubMed ID: 6773311
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats.
    Massacesi L; Castigli E; Vergelli M; Olivotto J; Abbamondi AL; Sarlo F; Amaducci L
    J Clin Invest; 1991 Oct; 88(4):1331-7. PubMed ID: 1918383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of antiepileptic drugs on immune system].
    Basta-Kaim A; Budziszewska B; Lasoń W
    Przegl Lek; 2008; 65(11):799-802. PubMed ID: 19205364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus caused by hydantoin preparations.
    Szegedi G; Petrányi G
    Ann Immunol Hung; 1972; 16(0):433-44. PubMed ID: 4607152
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 36. [A concept to be included in anesthesiology and resuscitation: their immunological interaction].
    Nalda MA; Pacheco García M
    Rev Esp Anestesiol Reanim; 1982 Nov; 29(6):333-9. PubMed ID: 7170371
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of Boicil on some immunocompetent cells. II. In vitro and in vivo modulation of the mouse cellular and humoral immune response.
    Olinescu A; Hristescu S; Poliopol M; Agache F; Kerek F
    Arch Roum Pathol Exp Microbiol; 1987; 46(2):147-58. PubMed ID: 3502686
    [No Abstract]   [Full Text] [Related]  

  • 38. [An approach to immune suppression: control of the immune response (author's transl)].
    Ramos A; Hoecker G
    Rev Med Chil; 1978 Apr; 106(4):296-302. PubMed ID: 663473
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects.
    Takeshita K; Fukazawa I; Nakaike S; Kameo K; Tomisawa K; Otomo S; Aihara H
    Drugs Exp Clin Res; 1988; 14(5):311-8. PubMed ID: 3219994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary effects observed in immunosuppressive therapy of patients with autoimmune disorders.
    Mosonyi L; Szemere P
    Mater Med Pol; 1973; 5(1):5-8. PubMed ID: 4774847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.